Evaluation of glutathione S-transferase P1 genetic variants affecting type-2 diabetes susceptibility and glycemic control

Archives of Medical Science

Volumn 8, Issue 4, 2012, Pages 631-636

  Amer, Mahmoud A ^a   Ghattas, Maivel H ^b   Abo ElMatty, Dina M ^c   Abou El Ela, Soad H ^c  

^a Sinai University   (Egypt)

^b Suez Canal University Faculty of Medicine   (Egypt)

^c Suez Canal University   (Egypt)

Author keywords

Body mass index; Glycated hemoglobin; GSTP1; Polymerase chain reaction restriction fragment length polymorphism; Type 2 diabetes mellitus

Indexed keywords

CHOLESTEROL; DNA; GLUCOSE; GLUTATHIONE TRANSFERASE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOLEUCINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VALINE;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD SAMPLING; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA EXTRACTION; EGYPT; EXON; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HETEROZYGOTE; HUMAN; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MUTANT; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING;

EID: 84866854104     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2012.30286     Document Type: Article

References (27)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-53. (Pubitemid 38579764)
2. Wautier MP, Chappey O, Corda S, Stern DM, Schmidt AM, Wautier JL. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab 2001; 280: 685-94.
3. Creager MA, Lüscher TF, Cosentino F, Beckman JA. Diabetes and vascular disease: pathophysiology, clinical consequences and medical therapy: part I. Circulation 2003; 108: 1527-32. (Pubitemid 37176462)
4. Tiedge M, Lortz S, Drinkgern J, Lenzen S. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 1997; 46: 1733-42. (Pubitemid 27456404)
5. Robertson RP, Harmon J, Tran PO, Tanaka Y, Takahashi H. Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes 2003; 52: 581-7. (Pubitemid 36323562)
6. Chasseaud LF. The role of glutathione and glutathione S-transferases in the metabolism of chemical carcinogens and other electrophilic agents. Adv Cancer Res 1979; 29: 175-274.
7. Wang G, Zhang L, Li Q. Genetic polymorphisms of GSTT1, GSTM1, and NQO1 genes and diabetes mellitus risk in Chinese population. Biochem Biophys Res Commun 2006; 341: 310-3. (Pubitemid 43152107)
8. Mao GE, Morris G, Lu QY, et al. Glutathione S-transferase P1 Ile105Val polymorphism, cigarette smoking and prostate cancer. Cancer Detect Prev 2004; 28: 368-74. (Pubitemid 39471284)
9. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86.
10. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-53.
11. Hertel JK, Johansson S, Raeder H, et al. Evaluation of four novel genetic variants affecting hemoglobin A1c levels in a population-based type 2 diabetes cohort (the HUNT2 study). BMC Med Genet 2011; 12: 20.
12. Miller DP, Neuberg D, de Vivo I, et al. Smoking and the risk of lung cancer: susceptibility with GSTP1 polymorphisms. Epidemiology 2003; 14: 545-51. (Pubitemid 40417035)
13. Park JH, El Sohemy A, Cornelis MC, Kim HA, Kim SY, Bae SC. Glutathione S-transferase M1, T1, and P1 gene polymorphisms and carotid atherosclerosis in Korean patients with rheumatoid arthritis. Rheumatol Int 2004; 24: 157-63. (Pubitemid 38797629)
14. Palmer CN, Young V, Ho M, Doney A, Belch JJ. Association of common variation in glutathione S-transferase genes with premature development of cardiovascular disease in patients with systemic sclerosis. Arthritis Rheum 2003; 48: 854-5. (Pubitemid 36302025)
15. Ramprasath T, Senthil Murugan P, Prabakaran AD, Gomathi P, Rathinavel A, Selvam GS. Potential risk modifications of GSTT1, GSTM1 and GSTP1 (glutathione- S-transferases) variants and their association to CAD in patients with type-2 diabetes. Biochem Biophys Res Commun 2011; 407: 49-53.
16. Yalin S, Hatungil R, Tamer L, et al. Glutathione S-trans - ferase gene polymorphisms in Turkish patients with diabetes mellitus. Cell Biochem Funct 2007; 25: 509-13. (Pubitemid 47436090)
17. American Diabetes Association. Diagnosis and Class - ification of Diabetes Mellitus. Diabetes Care 2007; 30: S42-7.
18. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
19. Chobanian AV, Bakris GL, Black HR, et al National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-72. (Pubitemid 37430158)
20. Harries LW, Stubbins MJ, Forman D, Howard GC, Wolf CR. Identification of genetic polymorphisms at the glutathione S-transferase pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 1997; 18: 641-4. (Pubitemid 28132446)
21. Lehmann R, Schleicher ED. Molecular mechanisms of diabetic nephropathy. Clin Chim Acta 2000; 297: 135-44.
22. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995; 30: 445-600.
23. Bid HK, Konwar R, Saxena M, Chaudhari P, Agrawal CG, Banerjee M. Association of glutathione S-transferase (GSTM1, T1 and P1) gene polymorphisms with type 2 diabetes mellitus in north Indian population. J Postgrad Med 2010; 56: 176-81.
24. Oniki K, Umemoto Y, Nagata R, et al. Glutathione S-transferase A1 polymorphism as a risk factor for smoking-related type 2 diabetes among Japanese. Toxicol Lett 2008; 178: 143-5.
25. Alshagga MA, Mohamed N, Suhid AN, Ibrahim IA, Zakaria SZS. Frequencies of glutathione s-transferase (GSTM1, GSTM3 AND GSTT1) polymorphisms in a Malaysian population. Arch Med Sci 2011; 7: 572-8.
26. Turner RC, Millns H, Neil HA, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United kingdom prospective diabetes study (UKPDS: 23). BMJ 1998; 316: 823-8. (Pubitemid 28112428)
27. Willi, C, Bodenmann, P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2007; 298: 2654-64. (Pubitemid 350254957)